Research graph
References from Definitive radio(chemo)therapy versus upfront surgery in the treatment of HPV-related localized or locally advanced oropharyngeal squamous cell carcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Human papillomavirus-related oropharyngeal cancer
10.1093/annonc/mdx304 · 2017 · External reference
Unresolved reference
External reference
Worldwide burden of cancer attributable to HPV by site, country and HPV type
10.1002/ijc.30716 · 2017 · External reference
A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide
10.3390/v13071326 · 2021 · External reference
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer.
10.1056/nejmoa0912217 · 2010 · External reference
Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer
10.1038/bjc.2017.132 · 2017 · External reference
Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
10.1016/j.annonc.2020.07.011 · 2020 · External reference
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022
10.6004/jnccn.2022.0016 · 2022 · External reference
Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison
10.1038/sj.bjc.6602696 · 2005 · External reference
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
10.1016/s1470-2045(19)30410-3 · 2019 · External reference
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis
10.1093/annonc/mdu004 · 2014 · External reference
Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma
10.1001/jamaoto.2015.0764 · 2015 · External reference
Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer
10.1016/j.oraloncology.2018.02.017 · 2018 · External reference
Survivorship and Quality of Life in Head and Neck Cancer
10.1200/jco.2015.61.4115 · 2015 · External reference
Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric study
10.1016/j.ejso.2020.12.011 · 2021 · External reference
Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and Implications
10.1007/s11912-019-0799-x · 2019 · External reference
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology
10.1093/jnci/85.5.365 · 1993 · External reference
Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35
10.1200/jco.1999.17.3.1008 · 1999 · External reference
Radiotherapy versus Surgery in Early-Stage HPV-Positive Oropharyngeal Cancer
10.4143/crt.2021.441 · 2022 · External reference
Primary surgery versus primary radiation-based treatment for locally advanced oropharyngeal cancer
10.1002/lary.26903 · 2018 · External reference
Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study
10.1016/j.oraloncology.2017.01.012 · 2017 · External reference
Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis
10.1016/j.oraloncology.2018.09.018 · 2018 · External reference
Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options
10.3390/curroncol28030156 · 2021 · External reference
Quality of life in survivors of oropharyngeal cancer: A systematic review and meta-analysis of 1366 patients
10.1016/j.ejca.2017.03.006 · 2017 · External reference
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
10.1016/s1470-2045(10)70290-4 · 2011 · External reference
Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires
10.1186/1471-2407-11-128 · 2011 · External reference
Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial
2022 · External reference
Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer
10.1001/jamaoto.2016.0656 · 2016 · External reference
Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation
10.1016/j.radonc.2013.08.010 · 2013 · External reference
Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up
10.1016/j.radonc.2015.12.024 · 2016 · External reference
Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial
10.1007/s00520-017-3946-7 · 2018 · External reference
Quality of life, HPV-status and phase angle predict survival in head and neck cancer patients under (chemo)radiotherapy undergoing nutritional intervention: Results from the prospective randomized HEADNUT-trial.
10.1016/j.radonc.2021.11.011 · 2022 · External reference
The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer.
10.1038/sj.bjc.6604248 · 2008 · External reference
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials
10.1016/s1470-2045(09)70200-1 · 2009 · External reference
Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials
10.1002/cncr.31556 · 2018 · External reference
The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the “Real-World”: Results from the Population-Based PROFILES Registry
10.1634/theoncologist.2019-0348 · 2020 · External reference
Modified Head and Neck Swallow Scale: Using EORTC-QLQ-H&N35 to Predict Overall Survival
10.1002/lary.29559 · 2021 · External reference
Long-Term Aspects of Quality of Life in Head and Neck Cancer Patients Treated With Intensity Modulated Radiation Therapy: A 5-Year Longitudinal Follow-up and Comparison with a Normal Population Cohort
10.1016/j.adro.2019.07.015 · 2019 · External reference
The course of health-related quality of life from diagnosis to two years follow-up in patients with oropharyngeal cancer: does HPV status matter?
10.1007/s00520-020-05932-w · 2021 · External reference
Factors associated with the quality of life for hospitalized patients with HPV-associated oropharyngeal squamous cell carcinoma
10.1016/j.oraloncology.2020.104590 · 2020 · External reference
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial
10.1200/jco.21.01961 · 2022 · External reference
